Showing results (11-20 of 87) with videos related to
Sort By:
Pageof 9
Physiology International|May 18, 2023
NUSAP1 regulates basal cell carcinoma migration, invasion and DNA damage through activation of the Hedgehog signaling pathwayYanjun Zhu, Yan Liu, Liwen Zhang, et al.Environmental Research|January 5, 2025
Achieving stable partial nitrification by exploiting lag phase of NOB recovery for selective washoutDong Li, Luyao Teng, Kehuan Guo, et al.Medicine|February 24, 2023
The impact of Teach-back method on preoperative anxiety and surgical cooperation in elderly patients undergoing outpatient ophthalmology surgery: A randomized clinical trialDan Shen, Weiyi Huang, Shujin Wei, et al.Neoplasia (New York, N.Y.)|July 30, 2023
Effects of PYCR1 on prognosis and immunotherapy plus tyrosine kinase inhibition responsiveness in metastatic renal cell carcinoma patientsXianglai Xu, Ying Wang, Xinyu Hu, et al.Immunogenetics|December 14, 2022
Unfavorable immunotherapy plus tyrosine kinase inhibition outcome of metastatic renal cell carcinoma after radical nephrectomy with increased ADAM9 expressionXianglai Xu, Ying Wang, Zhaoyi Chen, et al.Cancer Management and Research|September 22, 2018
Checkpoint molecule PD-1-assisted CD8+ T lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitorsJiaxi Yao, Wei Xi, Yanjun Zhu, et al.Cancer Medicine|April 9, 2023
HMOX1 pathway signature predicts clinical benefit from immunotherapy plus tyrosine kinase inhibitor therapy in advanced renal cell carcinomaXianglai Xu, Sihong Zhang, Ying Wang, et al.Scandinavian Journal of Immunology|June 9, 2023
The prognostic significance of CDK6 expression in renal cell carcinoma treated by immune checkpoint plus tyrosine kinase inhibitionJiajun Wang, Sihong Zhang, Ying Wang, et al.Current Medical Imaging|September 20, 2022
α-Cyanoacrylate Rapid Medical Adhesive (Medical EC Glue) Localization of Pulmonary Nodules Guided by Computed Tomography before Thoracoscopic SurgeryYinghui Liu, Zhonghui Hou, Ke Wu, et al.Urologic Oncology|November 3, 2022
Alternative Complement Pathway Signature Determines Immunosuppression and Resistance to Immunotherapy Plus Tyrosine Kinase Inhibitor Combinations in Renal Cell CarcinomaJiajun Wang, Sihong Zhang, Ying Wang, et al.Pageof 9